Orencia

(abatacept)
0.4 ML abatacept 125 MG/ML Prefilled Syringe [Orencia]0.7 ML abatacept 125 MG/ML Prefilled Syringe [Orencia]
View 3 more
NO BOXED WARNING

Dosage & administration

Intravenous Use for Adult RA (2.1) and Adult PsA (2.3)

Body Weight of PatientDoseNumber of Vials

Less than 60 kg

500 mg

2

60 to 100 kg

750 mg

3

More than 100 kg

1,000 mg

4

Subcutaneous Use for Adult RA (2.1)


Intravenous Use for pJIA in Pediatric Patients ≥6 Years Old (2.2)


Subcutaneous Use for pJIA in Pediatric Patients ≥2 Years Old (2.2)


Body Weight of Pediatric PatientDose (once weekly)

10 kg to less than 25 kg

50 mg

25 kg to less than 50 kg

87.5 mg

50 kg or more

125 mg

Subcutaneous Use for Adult PsA


Intravenous Use for prophylaxis of aGVHD (2.4)


Preparation and Administration Instructions


drug label

Orencia prescribing information

prior authorization

Orencia prior authorization resources

Most recent Orencia prior authorization forms

View By Payer
Verified: Feb 07, 2024Kaiser Foundation Health Plan - Chronic High-Dose Opioid Therapy Prior Authorization Form Washington
Verified: Feb 01, 2024Highmark BCBS Northeastern NY - Medicare Prescription Drug Medication Request Form
Verified: Feb 01, 2024Highmark BCBS Northeastern NY - Short Acting Opioid Prior Authorization Form
Verified: Feb 01, 2024Highmark BCBS Western NY - Specialty Drug Prior Authorization Form
Verified: Feb 01, 2024Highmark BCBS Western NY - Non-Formulary Drug Coverage Prior Authorization Form

Most recent state uniform prior authorization forms

Verified: Feb 27, 2024Arizona - Uniform Prior Authorization Form
Verified: Feb 27, 2024Colorado - Uniform Prior Authorization Form
Verified: Feb 27, 2024Hawaii - Uniform Prior Authorization Form
Verified: Feb 27, 2024Illinois - Uniform Prior Authorization Form
Verified: Feb 27, 2024Indiana - Uniform Prior Authorization Form
Verified: Feb 27, 2024Louisiana - Uniform Prior Authorization Form
Verified: Feb 27, 2024Michigan - Uniform Prior Authorization Form
Verified: Feb 27, 2024Minnesota - Uniform Prior Authorization Form
Verified: Feb 27, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Feb 27, 2024New Mexico - Uniform Prior Authorization Form
Verified: Feb 27, 2024Oregon - Uniform Prior Authorization Form
Verified: Feb 27, 2024Texas - Uniform Prior Authorization Form
Orencia On Call Enrollment Form
Orencia On Call Online Portal
Learn More

Benefits investigation

Orencia On Call Enrollment Form
Orencia On Call Online Portal
Learn More

Financial Assistance

Financial Assistance Programs

Orencia retails for $1,513 per dose without insurance or financial assistance.Depending on your patient's insurance situation and other eligibility criteria, they may be able to get Orencia for significantly less. Review the program information below to determine what program can offer your patient the most benefits.
CoPay Card Program$5 Co Pay
Available for
commercial
Program Details
  • $1513 for Powder
  • Program Expires Calendar Year
  • $15000 Annual Cap
Forms
Orencia On Call Enrollment Form
Orencia On Call Online Portal
Enroll in Patient Savings Program

PubMed™ | Orencia

Orencia PubMed™ News

patient education

Orencia patient education

Getting started on Orencia

Instructions For Use (Prefilled Syringe): RA, pJIA & PsA
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Instructions for Use (ClickJect Autoinjector): RA & PsA
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

Orencia pJIA Observational Registry Guide
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Orencia: RA
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Orencia: RA, pJIA & PsA
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Stories
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Videos
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Orencia: PsA
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Orencia: pJIA
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Orencia On Call Support Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Treatment Journal
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Dual Seropositive Questions
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Orencia Patient Brochure: English
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Orencia Patient Brochure: Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

people also ask

Orencia FAQs

Is there a pregnancy exposure registry for ORENCIA?Yes, there is a pregnancy exposure registry for ORENCIA that monitors pregnancy outcomes in women exposed to the drug during pregnancy. Healthcare professionals are encouraged to register patients and pregnant women are encouraged to enroll themselves by calling 1-877-311-8972.
What is the risk associated with ORENCIA use during pregnancy?The data with ORENCIA use in pregnant women are insufficient to inform on drug-associated risk. However, there are clinical considerations for administering live vaccines to infants who were exposed to ORENCIA while in utero (see Clinical Considerations).
What are the clinical considerations for administering live vaccines to infants who were exposed to ORENCIA while in utero?It is unknown if abatacept, the active ingredient in ORENCIA, can cross the placenta into the fetus when a woman is treated with the drug during pregnancy. It is also unknown if the immune response of an infant who was exposed in utero to abatacept and subsequently administered a live vaccine is impacted. Risks and benefits should be considered prior to vaccinating such infants.
Is ORENCIA safe to use during lactation?There is no information regarding the presence of abatacept, the active ingredient in ORENCIA, in human milk, the effects on the breastfed infant, or the effects on milk production. However, abatacept was present in the milk of lactating rats dosed with the drug.
Is ORENCIA safe to use in pediatric patients?ORENCIA is safe and effective for reducing signs and symptoms in pediatric patients 2 years of age and older with moderately to severely active polyarticular juvenile idiopathic arthritis (pJIA). Use of ORENCIA for this indication is supported by evidence from clinical studies. The safety and effectiveness of ORENCIA use in pJIA in pediatric patients less than two years of age have not been established.
Can geriatric patients use ORENCIA for Rheumatoid Arthritis?Yes, geriatric patients (patients aged 65 years of age and older) can use ORENCIA for Rheumatoid Arthritis. Clinical studies involving 323 patients aged 65 years and older, including 53 patients aged 75 years and older, showed no overall differences in safety or effectiveness between geriatric patients and younger adults. However, caution should be used when treating geriatric patients due to the higher incidence of infections and malignancies in the geriatric population in general. The frequency of serious infection and malignancy among ORENCIA-treated patients over age 65 was higher than for those under age 65.
Are there differences in response between geriatric patients and younger adult patients using ORENCIA for Rheumatoid Arthritis?Other reported clinical experience has not identified differences in responses between geriatric patients and younger adults when using ORENCIA for Rheumatoid Arthritis. However, greater sensitivity of some geriatric patients cannot be ruled out. Clinical studies of ORENCIA for acute graft versus host disease (aGVHD) did not include sufficient numbers of patients 65 years of age and older to determine whether they respond differently from younger adult patients.
FAQ Data Source